A molecular pathway analysis of the glutamatergic-monoaminergic interplay serves to investigate the number of depressive records during citalopram treatment.
about
A molecular pathway analysis of the glutamatergic-monoaminergic interplay serves to investigate the number of depressive records during citalopram treatment.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
A molecular pathway analysis o ...... s during citalopram treatment.
@en
A molecular pathway analysis o ...... s during citalopram treatment.
@nl
type
label
A molecular pathway analysis o ...... s during citalopram treatment.
@en
A molecular pathway analysis o ...... s during citalopram treatment.
@nl
prefLabel
A molecular pathway analysis o ...... s during citalopram treatment.
@en
A molecular pathway analysis o ...... s during citalopram treatment.
@nl
P2860
P50
P1476
A molecular pathway analysis o ...... s during citalopram treatment.
@en
P2093
Concetta Crisafulli
P2860
P2888
P304
P356
10.1007/S00702-014-1267-2
P577
2014-07-02T00:00:00Z